8 companies structurally similar to Regeneron Pharmaceuticals, Inc. (REGN) — identified by peer analysis across revenue dynamics, margin profile, capital efficiency and growth patterns. Not based on sector labels alone.
Companies similar to Regeneron Pharmaceuticals, Inc. cluster around comparable structural characteristics, with the strongest visible overlap typically appearing in valuation. Examples in this group include Sanofi, Qiagen N.V., Amgen Inc..
| # | Company | Peer score | |
|---|---|---|---|
| #1 |
SAN.PA · Healthcare
|
46 |
Analysis REGN vs SAN.PA |
| #2 |
QIA.DE · Healthcare
|
62 |
Analysis REGN vs QIA.DE |
| #3 |
AMGN · Healthcare
|
63 |
Analysis REGN vs AMGN |
| #4 |
VRSK · Industrials
|
75 |
Analysis REGN vs VRSK |
| #5 |
VRTX · Healthcare
|
71 |
Analysis REGN vs VRTX |
| #6 |
EW · Healthcare
|
54 |
Analysis REGN vs EW |
| #7 |
DGE.L · Consumer Defensive
|
50 |
Analysis REGN vs DGE.L |
| #8 |
DHR · Healthcare
|
40 |
Analysis REGN vs DHR |
Peer-relative comparison across valuation, quality, growth and stability.
See how Regeneron Pharmaceuticals, Inc. ranks within its sector on specific metrics.
Full interactive peer view with similarity scores, compare tool and portfolio integration.
Peer similarity is rule-based and descriptive only. Based on structural analysis of revenue, margins, capital intensity and growth patterns. Not investment advice.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.